Terms: = Liver cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Treatment
50 results:
1. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
2. Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial.
Lu S; Chen J; Zhang R; Luo T; Ma L; Xu P; Ding H; Zeng X; Wu B; Shi Y; Liu C; Mu Y; Chen S; Wang J
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):5-12. PubMed ID: 38236640
[TBL] [Abstract] [Full Text] [Related]
3. The decreased risk of hepatocellular carcinoma in hepatitis B virus-related cirrhotic portal hypertension patients after laparoscopic splenectomy and azygoportal disconnection.
Gao TM; Xiao KQ; Xiang XX; Jin SJ; Qian JJ; Zhang C; Zhou BH; Tang H; Bai DS; Jiang GQ
Surg Endosc; 2023 Nov; 37(11):8522-8531. PubMed ID: 37775601
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals.
Hong H; Choi WM; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Choi J
Gut Liver; 2024 Jan; 18(1):147-155. PubMed ID: 37076993
[TBL] [Abstract] [Full Text] [Related]
5. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract] [Full Text] [Related]
6. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty liver Disease-Related Hepatocellular cancer (NAFLD-HCC).
Chu J; Cholankeril G; Yu X; Rana A; Natarajan Y; El-Serag HB; Kramer J; Kanwal F
Dig Dis Sci; 2023 Mar; 68(3):1060-1070. PubMed ID: 35759159
[TBL] [Abstract] [Full Text] [Related]
8. Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
Singh D; Gupta M; Sarwat M; Siddique HR
Crit Rev Oncol Hematol; 2022 Aug; 176():103751. PubMed ID: 35752426
[TBL] [Abstract] [Full Text] [Related]
9. [Multivariate analysis of the effect of two liver resection methods on the survival outcome of patients with intrahepatic cholangiocarcinoma].
Han XS; Li QW; Guo PL; Li JJ
Zhonghua Yi Xue Za Zhi; 2022 May; 102(18):1364-1368. PubMed ID: 35545580
[No Abstract] [Full Text] [Related]
10. HFRU-Net: High-Level Feature Fusion and Recalibration UNet for Automatic liver and Tumor Segmentation in CT Images.
Kushnure DT; Talbar SN
Comput Methods Programs Biomed; 2022 Jan; 213():106501. PubMed ID: 34752959
[TBL] [Abstract] [Full Text] [Related]
11. [Study on the prognostic value of preoperative anti hepatitis B virus therapy in patients with hepatocellular carcinoma complicated with microvascular tumor thrombus and establishment of survival prediction model].
Zhang L; Yang JR; Xia L; Chen HQ; Chen XL; Qian XJ; Li YX; Yang JW; Hu XQ; Peng WW; Pan WD
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2203-2209. PubMed ID: 34333932
[No Abstract] [Full Text] [Related]
12. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
[TBL] [Abstract] [Full Text] [Related]
13. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
[TBL] [Abstract] [Full Text] [Related]
14. Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract cancer.
Ji GW; Wang K; Xia YX; Wang JS; Wang XH; Li XC
Ann Surg Oncol; 2021 Jul; 28(7):4018-4029. PubMed ID: 33230745
[TBL] [Abstract] [Full Text] [Related]
15. Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
An J; Kim HI; Chang S; Shim JH
PLoS One; 2020; 15(8):e0238078. PubMed ID: 32845895
[TBL] [Abstract] [Full Text] [Related]
16. Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Zhan QF; Ling SB; Deng YN; Shan QN; Ye QW; Xu SJ; Jiang GJ; Lu D; Wei XY; Zhuang L; Zhang W; Shen T; Cen BN; Xie HY; Liu JM; Wu J; Zheng SS; Yang Y; Xu X
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):349-357. PubMed ID: 32622826
[TBL] [Abstract] [Full Text] [Related]
17. Impact of Site-Specific Metastases on Surgical Value and Survival among Metastatic Colorectal cancer Patients.
Zong Z; Zhou TC; Tang FX; Tian HK; Wang A; Yi CH
Am Surg; 2020 Mar; 86(3):220-227. PubMed ID: 32223801
[TBL] [Abstract] [Full Text] [Related]
18. The impact of SVR from direct-acting antiviral- and interferon-based treatments for HCV on hepatocellular carcinoma risk.
Janjua NZ; Wong S; Darvishian M; Butt ZA; Yu A; Binka M; Alvarez M; Woods R; Yoshida EM; Ramji A; Feld J; Krajden M
J Viral Hepat; 2020 Aug; 27(8):781-793. PubMed ID: 32187430
[TBL] [Abstract] [Full Text] [Related]
19. Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review.
Zeng B; Yuan L; Chu J; Yang Y; Lin S
J Int Med Res; 2020 Mar; 48(3):300060519891018. PubMed ID: 31840543
[TBL] [Abstract] [Full Text] [Related]
20. Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study.
Jeon MY; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Lee JH; Yu SJ; Kim YJ; Yoon JH; Cho EJ; Kim SU
Gut Liver; 2020 Jul; 14(4):477-485. PubMed ID: 31640304
[TBL] [Abstract] [Full Text] [Related]
[Next]
